Related Experiment Videos
Pharmacokinetic drug interactions with antimicrobial agents
J G Gillum1, D S Israel, R E Polk
1School of Pharmacy, Virginia Commonwealth University, Medical College of Virginia, Richmond.
Clinical Pharmacokinetics
|December 1, 1993
Summary
Antimicrobial drugs can commonly interact with other medications by altering liver metabolism, primarily through cytochrome P450 enzyme inhibition or induction. Understanding these drug interactions is key to preventing adverse effects in patients.
Area of Science:
- Pharmacology
- Drug Metabolism
- Antimicrobial Agents
Background:
- Pharmacokinetic drug interactions involving antimicrobials are increasingly common with new and existing drug classes.
- These interactions often occur due to alterations in hepatic metabolism of co-administered drugs.
Purpose of the Study:
- To elucidate the mechanisms by which antimicrobial agents affect the biotransformation of other drugs.
- To identify specific cytochrome P450 enzymes involved in these interactions.
Main Methods:
- Investigated the inhibitory and inductive effects of various antimicrobial classes (macrolides, fluoroquinolones, azoles, rifamycins) on cytochrome P450 enzymes.
- Utilized in vitro preparations of human enzymes to predict drug interactions.
Main Results:
- Macrolides and azoles inhibit specific cytochrome P450 enzymes (e.g., CYP3A4, CYP1A2).
- Rifampicin and rifabutin induce cytochrome P450 enzymes, enhancing drug metabolism.
- In vitro enzyme studies can predict potential adverse drug interactions.
Conclusions:
- Antimicrobial drug interactions are mediated by specific cytochrome P450 enzyme modulation.
- Variability in enzyme activity contributes to inter-patient differences in interaction frequency.
- Further research is needed to effectively inform clinicians and prevent undesirable drug interaction consequences.